Logo image of TRIB

TRINITY BIOTECH PLC-SPON ADR (TRIB) Stock Fundamental Analysis

NASDAQ:TRIB - US8964385046 - ADR

1.57 USD
+0.01 (+0.64%)
Last: 8/22/2025, 8:00:02 PM
1.54 USD
-0.03 (-1.91%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

2

TRIB gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of TRIB have multiple concerns. TRIB is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TRIB had negative earnings in the past year.
In the past year TRIB has reported a negative cash flow from operations.
TRIB had negative earnings in 4 of the past 5 years.
In multiple years TRIB reported negative operating cash flow during the last 5 years.
TRIB Yearly Net Income VS EBIT VS OCF VS FCFTRIB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M -100M

1.2 Ratios

TRIB has a Return On Assets of -30.78%. This is comparable to the rest of the industry: TRIB outperforms 41.71% of its industry peers.
Industry RankSector Rank
ROA -30.78%
ROE N/A
ROIC N/A
ROA(3y)-38.57%
ROA(5y)-23.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRIB Yearly ROA, ROE, ROICTRIB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

TRIB's Gross Margin of 34.83% is on the low side compared to the rest of the industry. TRIB is outperformed by 72.19% of its industry peers.
TRIB's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TRIB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.46%
GM growth 5Y-3.74%
TRIB Yearly Profit, Operating, Gross MarginsTRIB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

TRIB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TRIB remains at a similar level compared to 1 year ago.
TRIB has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, TRIB has an improved debt to assets ratio.
TRIB Yearly Shares OutstandingTRIB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
TRIB Yearly Total Debt VS Total AssetsTRIB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

TRIB has an Altman-Z score of -0.81. This is a bad value and indicates that TRIB is not financially healthy and even has some risk of bankruptcy.
TRIB has a Altman-Z score (-0.81) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.81
ROIC/WACCN/A
WACC8.14%
TRIB Yearly LT Debt VS Equity VS FCFTRIB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.28 indicates that TRIB should not have too much problems paying its short term obligations.
TRIB's Current ratio of 1.28 is on the low side compared to the rest of the industry. TRIB is outperformed by 78.61% of its industry peers.
TRIB has a Quick Ratio of 1.28. This is a bad value and indicates that TRIB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.68, TRIB is not doing good in the industry: 89.84% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.68
TRIB Yearly Current Assets VS Current LiabilitesTRIB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

TRIB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
Looking at the last year, TRIB shows a quite strong growth in Revenue. The Revenue has grown by 8.31% in the last year.
TRIB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.41% yearly.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y-8.8%
Revenue growth 5Y-7.41%
Sales Q2Q%18.09%

3.2 Future

TRIB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.68% yearly.
Based on estimates for the next years, TRIB will show a quite strong growth in Revenue. The Revenue will grow by 11.62% on average per year.
EPS Next Y65.8%
EPS Next 2Y34.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.13%
Revenue Next 2Y11.62%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TRIB Yearly Revenue VS EstimatesTRIB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
TRIB Yearly EPS VS EstimatesTRIB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -5 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

TRIB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TRIB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRIB Price Earnings VS Forward Price EarningsTRIB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRIB Per share dataTRIB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

TRIB's earnings are expected to grow with 34.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.68%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TRIB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRINITY BIOTECH PLC-SPON ADR

NASDAQ:TRIB (8/22/2025, 8:00:02 PM)

After market: 1.54 -0.03 (-1.91%)

1.57

+0.01 (+0.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)N/A N/A
Inst Owners4.64%
Inst Owner Change219.3%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap30.13M
Analysts85.71
Price TargetN/A
Short Float %9.81%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-128.03%
Min EPS beat(2)-272.55%
Max EPS beat(2)16.49%
EPS beat(4)1
Avg EPS beat(4)-116.51%
Min EPS beat(4)-272.55%
Max EPS beat(4)16.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.88%
Min Revenue beat(2)-9.97%
Max Revenue beat(2)-5.78%
Revenue beat(4)0
Avg Revenue beat(4)-6.76%
Min Revenue beat(4)-9.97%
Max Revenue beat(4)-1.38%
Revenue beat(8)1
Avg Revenue beat(8)-7.57%
Revenue beat(12)1
Avg Revenue beat(12)-11.44%
Revenue beat(16)3
Avg Revenue beat(16)-13.23%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.68
EYN/A
EPS(NY)-0.92
Fwd EYN/A
FCF(TTM)-0.74
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS3.21
BVpS-1.83
TBVpS-4.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.78%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.83%
FCFM N/A
ROA(3y)-38.57%
ROA(5y)-23.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.46%
GM growth 5Y-3.74%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 539.63%
Cap/Sales 16.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 0.68
Altman-Z -0.81
F-Score4
WACC8.14%
ROIC/WACCN/A
Cap/Depr(3y)316%
Cap/Depr(5y)319.23%
Cap/Sales(3y)10.22%
Cap/Sales(5y)10.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16%
EPS Next Y65.8%
EPS Next 2Y34.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.31%
Revenue growth 3Y-8.8%
Revenue growth 5Y-7.41%
Sales Q2Q%18.09%
Revenue Next Year10.13%
Revenue Next 2Y11.62%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.74%
OCF growth 3YN/A
OCF growth 5YN/A